House dust mite allergen extract in combination with CYT003-QbG10-placebo

DRUG2 trials

Sponsors

Cytos Biotechnology AG

Conditions

House Dust Mite AllergyPerennial Allergic Rhinoconjunctivitis

Phase 2

A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis

CompletedNCT00574704

Cytos Biotechnology AGHouse Dust Mite Allergy, Perennial Allergic Rhinoconjunctivitis

Start: 2006-09-30End: 2008-03-31Updated: 2013-07-11

A Study to Investigate an Immunomodulatory Therapy in Adult Patients With Perennial Allergic Rhinoconjunctivitis

CompletedNCT00574223

Cytos Biotechnology AGHouse Dust Mite Allergy, Perennial Allergic Rhinoconjunctivitis

Start: 2007-11-30End: 2009-03-31Target: 100Updated: 2009-04-27